Sunrise, a Namur, Belgium-based home sleep testing company, raised €17M in funding.
The round was led by Kurma Partners with participation from VIVES IUF, Namur Invest Sambrinvest, IMBC, InvestBW, Sofinex and European Innovation Council.
The company intends to use the funds to commercialize its technology in the United States and hire new talent.
Led by CEO Laurent Martinot, Sunrise is a sleep apnoea diagnosis company, which brings clinical quality directly into the patient’s home. Its artificial intelligence-powered technology analyses a new signal on the human body, jaw movements, and other common apnoea signals, from a single sensor simply placed on the chin. Sunrise has already achieved a significant milestone in its international development: the approval of its second generation technology by the Food and Drug Administration (FDA) in America and the approval of the device under the recent Medical Device Regulation (MDR) in Europe.
The team currently consists of 30 people and has around 20 vacancies in Belgium, France and the United States.
The funding was in addition to the €12m Sunrise has raised since its inception.
FinSMEs
10/03/2023